Cardiff Oncology Ownership | Who Owns Cardiff Oncology?

Overview Forecast RevenueFinancials Chart Transcripts

Cardiff Oncology Ownership Summary

Cardiff Oncology is owned by 43.00% institutional investors, 6.05% insiders, and 50.94% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 5.92% of CRDF shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Cardiff Oncology shares.

CRDF Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cardiff Oncology	43.00%	6.05%	50.94%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	3.94M	5.92%	$12.40M
Blackrock	2.63M	5.88%	$5.84M
Vanguard group	2.28M	4.88%	$9.92M
Pfizer	2.41M	3.63%	$7.60M
Laurion capital management lp	1.80M	2.70%	$5.66M
Adage capital partners gp	1.42M	2.14%	$4.48M
Geode capital management	982.88K	2.10%	$4.27M
State street	848.58K	1.81%	$3.68M
Nuveen asset management	586.62K	1.25%	$2.55M
Morgan stanley	513.22K	1.15%	$1.14M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pfizer	2.41M	1.32%	$7.60M
Gsa capital partners llp	380.07K	0.12%	$1.65M
Laurion capital management lp	1.80M	0.10%	$5.66M
Elkhorn partners limited partnership	34.00K	0.08%	$107.10K
Findec wealth services	16.00K	0.03%	$32.96K
Callan capital	101.58K	0.03%	$440.84K
Avestar capital	140.47K	0.03%	$442.48K
Denver wealth management	15.23K	0.02%	$47.99K
Atom investors lp	71.05K	0.02%	$223.81K
Flputnam investment management	597.23K	0.02%	$1.23M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	2.63M	0.00%	1.95M
Laurion capital management lp	1.80M	0.10%	881.07K
Flputnam investment management	597.23K	0.02%	543.37K
Morgan stanley	513.22K	0.00%	433.80K
Susquehanna group, llp	258.64K	0.00%	258.64K

Top Sellers

Holder	Shares	% Assets	Change
Commodore capital lp	-	-	-5.38M
Orbimed advisors	-	-	-573.88K
Point72 asset management	-	-	-508.44K
Ikarian capital	-	-	-450.00K
Mai capital management	505.20K	0.01%	-434.40K

New Positions

Holder	Shares	% Assets	Change	Value
Atom investors lp	71.05K	0.02%	71.05K	$223.81K
Deutsche bank ag\	49.57K	0.00%	49.57K	$215.12K
Invst	36.00K	0.01%	36.00K	$73.80K
Metlife investment management	26.56K	0.00%	26.56K	$115.27K
Quadrature capital	23.12K	0.00%	23.12K	$72.93K

Sold Out

Holder	Change
Eversource wealth advisors	-2.00
True wealth design	-14.00
Newbridge financial services group	-17.00
Eagle bay advisors	-339.00
Macquarie group	-1.37K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	118	-4.84%	28,608,900	-11.55%	43	1.82%	63	-5.97%	22	15.79%
Mar 31, 2025	7	-94.44%	1,488,712	-94.70%	2	0.06%	4	-94.87%	1	-93.33%
Dec 31, 2024	121	35.96%	27,910,732	118.71%	59	8.03%	73	114.71%	15	-37.50%
Sep 30, 2024	88	-8.33%	12,508,364	-2.23%	26	3.25%	34	-45.16%	23	109.09%
Jun 30, 2024	96	17.07%	12,794,219	52.97%	28	8.17%	62	40.91%	11	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.08M	3.13%	-45.84K
iShares Russell 2000 ETF	1.49M	2.25%	-
Vanguard US Total Market Shares ETF	1.25M	1.89%	-
CREF Stock R1	1.25M	1.87%	17.50K
Vanguard Institutional Extnd Mkt Idx Tr	681.99K	1.03%	-310.76K
Fidelity Small Cap Index	621.56K	0.93%	26.45K
CREF Stock R3	443.15K	0.67%	-36.90K
Fidelity Extended Market Index	331.67K	0.50%	-2.73K
State St Russell Sm/Mid Cp® Indx SL Cl I	318.51K	0.48%	-
iShares Russell 2000 Value ETF	307.58K	0.46%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 30, 2025	PACE GARY W	-	Buy	$673.75K
Jul 30, 2025	PACE GARY W	-	Buy	$36.75K
Dec 17, 2024	Levine James E.	Chief Financial Officer	Buy	$14.91K
Dec 18, 2024	Levine James E.	Chief Financial Officer	Buy	$12.00K
Dec 16, 2024	Levine James E.	Chief Financial Officer	Buy	$9.82K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	2	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	6	-
2024 Q2	-	-

CRDF Ownership FAQ

Who Owns Cardiff Oncology?

Cardiff Oncology shareholders are primarily institutional investors at 43.00%, followed by 6.05% insiders and 50.95% retail investors. The average institutional ownership in Cardiff Oncology's industry, Biotech Stocks , is 307.10%, which Cardiff Oncology falls below.

Who owns the most shares of Cardiff Oncology?

Cardiff Oncology’s largest shareholders are Blackrock funding, inc. /de (3.94M shares, 5.92%), Blackrock (2.63M shares, 5.88%), and Vanguard group (2.28M shares, 4.88%). Together, they hold 16.68% of Cardiff Oncology’s total shares outstanding.

Does Blackrock own Cardiff Oncology?

Yes, BlackRock owns 5.88% of Cardiff Oncology, totaling 2.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.84M$. In the last quarter, BlackRock increased its holdings by 1.95M shares, a 287.98% change.

Who is Cardiff Oncology’s biggest shareholder by percentage of total assets invested?

Pfizer is Cardiff Oncology’s biggest shareholder by percentage of total assets invested, with 1.32% of its assets in 2.41M Cardiff Oncology shares, valued at 7.6M$.

Who is the top mutual fund holder of Cardiff Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cardiff Oncology shares, with 3.13% of its total shares outstanding invested in 2.08M Cardiff Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools